2 days Biogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine research analysts have rated…
Biogen (BIIB) · Nasdaq 100 · Science
X